The Vaccine: X is reputed journal publishes research related to Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Veterinary. The ISSN of the journal is 2590-1362.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Vaccine: X |
|---|---|
| Publisher | Elsevier |
| Publication Country | RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX |
| ISSN | 2590-1362 |
| Publication Area | Immunology | Medicine, Research & Experimental |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Vaccine: X in 2026 is 2.7.
The Vaccine: X is ranked in Q1.
The Vaccine: X is indexed in: DOAJ, Scopus, Web of Science, PubMed, Embase, UGC CARE Group 2.
There is a fee to publish in the Vaccine: X. The publication fee is 2000 USD.
The journal also offers a fee waiver policy.
The Vaccine: X takes an average of 13 weeks to publish research papers.
The official website of the journal is https://www.journals.elsevier.com/vaccine-x.
Please visit only official website of the journal to submit research papers.